Cannabis and Exercise: Peer-Reviewed Research Consensus

46 studies analyzedLast updated March 7, 2026

Overview

The research base for cannabis and exercise includes 46 peer-reviewed studies spanning 2012–2026. Of these, 3 provide strong evidence, including 1 meta-analyses and 6 randomized controlled trials. Key findings with strong support include: rigorous crossover trial found cbd at 50 mg and 300 mg did not improve or impair running performance, mood, or perceived exertion in trained athletes, and large national survey finds cannabis users are 24% more likely to be physically active, with the strongest association in states with legal recreational cannabis. However, several findings remain debated, and the evidence is not uniform across all areas. Many studies have methodological limitations including small sample sizes, short follow-up periods, and reliance on self-reported data.

What the Research Shows

Findings supported by multiple peer-reviewed studies. Stronger evidence means more consistency across study types.

Rigorous crossover trial found CBD at 50 mg and 300 mg did not improve or impair running performance, mood, or perceived exertion in trained athletes

Strong Evidence
1 study|Acute single-dose design; chronic CBD use effects not assessed. Sample of trained runners may not generalize to other athletes or recreational exercisers. Three conditions in crossover design may not

Large national survey finds cannabis users are 24% more likely to be physically active, with the strongest association in states with legal recreational cannabis

Moderate Evidence
3 studies|Based on limited number of strong-evidence studies.

Where Scientists Disagree

Areas where research shows conflicting results or ongoing scientific debate.

Review found THC is generally performance-impairing despite WADA prohibition, with impaired reaction time, coordination, and strength, contrasting with caffeine's clear ergogenic effects

Moderate Evidence
6 studies|Narrative review may not capture all relevant studies. THC effects vary by dose, timing, tolerance, and individual sensitivity. Most exercise-THC studies were conducted in non-athletes. The specific c

Systematic review found that exercise, massage, acupuncture, several medication classes, and lifestyle factors all upregulate the endocannabinoid system, relevant to conditions like migraine and fibromyalgia

Moderate Evidence
6 studies|Most of the evidence came from preclinical studies (in vitro and animal). Only 36 human studies were included, many with small sample sizes. The clinical significance of measured endocannabinoid chang

Systematic review of 15 studies finding THC does not improve aerobic performance or strength, inhibits exercise-induced asthma, and triggered angina at lower workloads in all cardiac-vulnerable subjects

Moderate Evidence
6 studies|Only 15 studies were found, reflecting the extremely limited research base. Many studies were older and used varying cannabis preparations, doses, and exercise protocols. The small number of studies p

Study of 79 young adults found aerobic fitness moderated cognitive deficits associated with cannabis use, with fitter users performing better after 3 weeks of abstinence

Moderate Evidence
6 studies|Cross-sectional design cannot determine causation. Relatively small sample. Cannot determine whether fit users had less severe use patterns or other protective factors. Three weeks of abstinence may n

What We Still Don't Know

  • Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
  • Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.

Evidence Breakdown

Distribution of study types in this research area. Higher-tier evidence (meta-analyses, RCTs) provides stronger conclusions.

Meta-Analyses & Systematic Reviews(Tier 1)
1 (2%)
Randomized Controlled Trials(Tier 2)
6 (13%)
Observational & Cohort(Tier 3-4)
12 (26%)
Reviews & Scoping(Tier 4)
14 (30%)
Other
13 (28%)

Key Studies

The most impactful research in this area.

Exercise consistently raises endocannabinoid levels in the body

The "runner's high" has traditionally been attributed to endorphins, but this research suggests the endocannabinoid system plays a major role in exercise-induced mood elevation and pain relief.

2022

CBD at 50mg or 300mg Did Not Improve or Impair Running Performance in Trained Athletes

Athletes increasingly use CBD for recovery and other health purposes. This rigorous trial provides reassurance that acute CBD use at common doses does not impair performance, while also finding no performance enhancement.

2025

High-Intensity Exercise Did Not Repair Brain Changes From Cannabis Use Disorder

Exercise has been proposed as a potential treatment for addiction, but this rigorous trial found it did not reverse CUD-related brain changes while people kept using. The strong adherence rate is the silver lining -- it shows people with CUD can commit to structured exercise programs, which could po

2025

CBD Did Not Enhance the Exercise Experience in a Running Trial

CBD is increasingly marketed to athletes. This trial found no enhancement of exercise experience, providing evidence against marketing claims while confirming CBD does not impair exercise.

2024

CBD Altered Exercise Physiology Without Hurting Performance in Trained Runners

Athletes are increasingly using CBD for recovery and performance. This is among the first controlled studies examining CBD's acute effects on exercise physiology, finding it changes metabolic responses without impairing performance.

2022

Daily cycling exercise improved sleep during inpatient cannabis withdrawal

Sleep disturbance is one of the most common and distressing symptoms of cannabis withdrawal, often driving relapse. Finding non-pharmacological interventions that improve sleep during this critical period could support more successful cessation.

2021

Research Timeline

How our understanding of this topic has evolved.

2010–2014

4 studies published. Predominantly observational and review studies.

2015–2019

6 studies published. Predominantly observational and review studies.

2020–present

36 studies published. Includes 1 meta-analyses, 6 RCTs, 3 strong-evidence studies.

About This Consensus

This consensus synthesizes 46 peer-reviewed studies: 1 meta-analyses (2%), 6 randomized controlled trials (13%), 12 observational studies (26%), 14 reviews (30%), 13 other study types (28%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.

This page synthesizes findings from 46 peer-reviewed studies. It is not medical advice. Always consult a healthcare provider for personal health decisions.